Clinical Trial Update: An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327) [Phase 3]

View source ↗

Summary

Phase 3 trial update on an approved drug being studied for a new indication in seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Seasonal Allergic Rhinitis

Snippet

Sponsor: Organon and Co | Conditions: Rhinitis, Allergic, Seasonal | Phase 3 | Status: COMPLETED